Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

NEW YORK--(BUSINESS WIRE)-- Pfizer Inc. invites investors and the general public to listen to a webcast of a discussion with Mace Rothenberg, Senior Vice President, Clinical Development and Medical Affairs, Oncology Business Unit, at the Goldman Sachs 32nd Annual Global Healthcare Conference on Tuesday, June 7, 2011 at 3:30 p.m. Pacific Daylight Saving Time.

To listen to the webcast, visit our web site at www.pfizer.com and click on the “Goldman Sachs 32nd Annual Global Healthcare Conference” link in Tab 2 of the Investor Presentations section located on the lower right-hand corner of that page. Information on accessing and pre-registering for the webcast will be available at www.pfizer.com beginning today.

Visitors will be able to listen to an archived copy of the webcast at www.pfizer.com.



CONTACT:

Pfizer Inc.
Media:
Joan Campion, 212-733-2798
or
Investors:
Jennifer Davis, 212-733-0717

KEYWORDS:   United States  North America  New York

INDUSTRY KEYWORDS:   Health  Oncology  Pharmaceutical  Professional Services  Finance

MEDIA:

Logo
 Logo

Webinar

Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.